Source: http://www.ecfr.gov/cgi-bin/text-idx?c=ecfr&tpl=/ecfrbrowse/Title21/21cfr26_main_02.tpl
Timestamp: 2014-09-23 12:22:27
Document Index: 421559727

Matched Legal Cases: ['art 26', 'ART 26', '§26', '§26', '§26', '§26', '§26', '§26', '§26', '§26', '§26', '§26', '§26', '§26', '§26', '§26', '§26', '§26', '§26', '§26', '§26', '§26', '§26', '§26', '§26', '§26', '§26', '§26', '§26', '§26', '§26', '§26', '§26', '§26', '§26', '§26', '§26', '§26', '§26']

Title 21 → Chapter I → Subchapter A → Part 26TITLE 21—Food and Drugs
CHAPTER I—FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICESSUBCHAPTER A—GENERALPART 26—MUTUAL RECOGNITION OF PHARMACEUTICAL GOOD MANUFACTURING PRACTICE REPORTS, MEDICAL DEVICE QUALITY SYSTEM AUDIT REPORTS, AND CERTAIN MEDICAL DEVICE PRODUCT EVALUATION REPORTS: UNITED STATES AND THE EUROPEAN COMMUNITY
§26.0
§26.4
Equivalence assessment.
§26.8
§26.9
§26.10
§26.11
§26.12
§26.13
§26.14
§26.15
§26.16
§26.17
Role and composition of the Joint Sectoral Committee.
Regulatory collaboration.
§26.19
§26.20
§26.21
Length and purpose of transition period.
Listing of CAB's.
Other transition period activities.
Start of the operational period.
Exchange and endorsement of quality system evaluation reports.
Exchange and endorsement of product evaluation reports.
Transmission of quality system evaluation reports.
Transmission of product evaluation reports.
Listing of additional CAB's.
Alert system and exchange of postmarket vigilance reports.
§26.60
§26.61
§26.62
§26.63
General coverage of this part.
§26.64
§26.65
§26.66
§26.67
§26.68
§26.69
§26.70
§26.71
§26.72
Sectoral contact points.
§26.73
§26.74
Preservation of regulatory authority.
§26.75
§26.76
§26.77
§26.78
§26.79
§26.80
Entry into force, amendment, and termination.
§26.81